Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF HUMAN SONIC HEDGEHOG N-TERMINAL DOMAIN
 
Authors :  P. A. Boriack-Sjodin, R. B. Pepinsky, E. A. Garber, L. F. Silvian
Date :  05 Mar 10  (Deposition) - 16 Mar 10  (Release) - 16 Mar 10  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  1.85
Chains :  Asym. Unit :  A,B
Biol. Unit 1:  A  (1x)
Biol. Unit 2:  B  (1x)
Keywords :  Hedgehog Proteins, Signaling, Zinc Ions, Sulfate Ions, Autocatalytic Cleavage, Cell Membrane, Developmental Protein, Glycoprotein, Holoprosencephaly, Hydrolase, Lipoprotein, Membrane, Microphthalmia, Palmitate, Protease, Secreted, Signaling Protein (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  R. B. Pepinsky, P. Rayhorn, E. S. Day, A. Dergay, K. P. Williams, A. Galdes, F. R. Taylor, P. A. Boriack-Sjodin, E. A. Garber
Mapping Sonic Hedgehog-Receptor Interactions By Steric Interference.
J. Biol. Chem. V. 275 10995 2000
PubMed-ID: 10753901  |  Reference-DOI: 10.1074/JBC.275.15.10995

(-) Compounds

Molecule 1 - SONIC HEDGEHOG PROTEIN
    ChainsA, B
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System StrainBL21(DE3)
    Expression System Taxid562
    Expression System VectorPET11D
    Expression System Vector TypePLASMID
    FragmentSONIC HEDGEHOG PROTEIN N-PRODUCT
    GeneSHH
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymSHH, HHG-1, SONIC HEDGEHOG PROTEIN N-PRODUCT

 Structural Features

(-) Chains, Units

  12
Asymmetric Unit AB
Biological Unit 1 (1x)A 
Biological Unit 2 (1x) B

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (2, 11)

Asymmetric Unit (2, 11)
No.NameCountTypeFull Name
1SO49Ligand/IonSULFATE ION
2ZN2Ligand/IonZINC ION
Biological Unit 1 (1, 3)
No.NameCountTypeFull Name
1SO43Ligand/IonSULFATE ION
2ZN-1Ligand/IonZINC ION
Biological Unit 2 (1, 6)
No.NameCountTypeFull Name
1SO46Ligand/IonSULFATE ION
2ZN-1Ligand/IonZINC ION

(-) Sites  (11, 11)

Asymmetric Unit (11, 11)
No.NameEvidenceResiduesDescription
01AC1SOFTWAREHIS A:140 , ASP A:147 , GLU A:176 , HIS A:182BINDING SITE FOR RESIDUE ZN A 200
02AC2SOFTWAREARG A:163 , HOH A:211 , HOH A:242 , HOH A:248BINDING SITE FOR RESIDUE SO4 A 701
03AC3SOFTWARELYS A:87 , ARG A:123 , ARG A:153 , HOH A:719BINDING SITE FOR RESIDUE SO4 A 702
04AC4SOFTWAREARG A:101 , LYS A:105 , HOH A:250 , HOH A:272BINDING SITE FOR RESIDUE SO4 A 705
05AC5SOFTWAREHIS B:140 , ASP B:147 , HIS B:182BINDING SITE FOR RESIDUE ZN B 700
06AC6SOFTWAREARG B:163 , HOH B:199 , HOH B:220BINDING SITE FOR RESIDUE SO4 B 201
07AC7SOFTWAREHOH B:16 , ARG B:28 , GLY B:29 , PHE B:30 , GLY B:31 , ARG B:33BINDING SITE FOR RESIDUE SO4 B 202
08AC8SOFTWAREARG B:33 , ARG B:34 , HIS B:35 , HOH B:319BINDING SITE FOR RESIDUE SO4 B 703
09AC9SOFTWARELYS B:87 , ARG B:123 , ARG B:153 , HOH B:213 , HOH B:259BINDING SITE FOR RESIDUE SO4 B 704
10BC1SOFTWAREHIS B:35 , GLY B:60 , ARG B:61 , HOH B:203 , HOH B:319 , HOH B:339 , HOH B:530 , HOH B:566BINDING SITE FOR RESIDUE SO4 B 1
11BC2SOFTWAREARG B:101 , LYS B:105BINDING SITE FOR RESIDUE SO4 B 2

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 3M1N)

(-) Cis Peptide Bonds  (3, 3)

Asymmetric Unit
No.Residues
1Ile A:48 -Pro A:49
2Gly B:25 -Pro B:26
3Ile B:48 -Pro B:49

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (36, 72)

Asymmetric Unit (36, 72)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_062593P26LSHH_HUMANDisease (HPE3)  ---A/BP26L
02UniProtVAR_039888G27ASHH_HUMANDisease (HPE3)  ---A/BG27A
03UniProtVAR_003619G31RSHH_HUMANDisease (HPE3)28936675A/BG31R
04UniProtVAR_062594L39PSHH_HUMANDisease (HPE3)  ---A/BL39P
05UniProtVAR_062595E53KSHH_HUMANDisease (HPE3)  ---A/BE53K
06UniProtVAR_062596D83VSHH_HUMANDisease (HPE3)  ---A/BD83V
07UniProtVAR_062597I84FSHH_HUMANDisease (HPE3)  ---A/BI84F
08UniProtVAR_009163D88VSHH_HUMANDisease (HPE3)104894050A/BD88V
09UniProtVAR_009164Q100HSHH_HUMANDisease (HPE3)587778792A/BQ100H
10UniProtVAR_062598C102RSHH_HUMANDisease (HPE3)  ---A/BC102R
11UniProtVAR_062599C102YSHH_HUMANDisease (HPE3)  ---A/BC102Y
12UniProtVAR_062600L109FSHH_HUMANDisease (HPE3)  ---A/BL109F
13UniProtVAR_023806A110DSHH_HUMANDisease (HPE3)  ---A/BA110D
14UniProtVAR_062601A110TSHH_HUMANDisease (HPE3)  ---A/BA110T
15UniProtVAR_017883I111FSHH_HUMANDisease (SMMCI)104894049A/BI111F
16UniProtVAR_039889I111NSHH_HUMANDisease (HPE3)  ---A/BI111N
17UniProtVAR_009165N115KSHH_HUMANDisease (HPE3)267607047A/BN115K
18UniProtVAR_003620W117GSHH_HUMANDisease (HPE3)104894040A/BW117G
19UniProtVAR_003621W117RSHH_HUMANDisease (HPE3)104894040A/BW117R
20UniProtVAR_062602V124MSHH_HUMANDisease (HPE3)  ---A/BV124M
21UniProtVAR_062603E136KSHH_HUMANDisease (HPE3)  ---A/BE136K
22UniProtVAR_039890H140PSHH_HUMANDisease (HPE3)  ---A/BH140P
23UniProtVAR_039891H140QSHH_HUMANDisease (HPE3)  ---A/BH140Q
24UniProtVAR_062604G143DSHH_HUMANDisease (HPE3)  ---A/BG143D
25UniProtVAR_062605R144PSHH_HUMANDisease (HPE3)  ---A/BR144P
26UniProtVAR_062606D147NSHH_HUMANDisease (HPE3)  ---A/BD147N
27UniProtVAR_062607T150KSHH_HUMANDisease (HPE3)  ---A/BT150K
28UniProtVAR_023807T150RSHH_HUMANDisease (HPE3)  ---A/BT150R
29UniProtVAR_062608S156RSHH_HUMANDisease (HPE3)  ---A/BS156R
30UniProtVAR_062609F170CSHH_HUMANDisease (HPE3)  ---A/BF170C
31UniProtVAR_062610D171HSHH_HUMANDisease (HPE3)  ---A/BD171H
32UniProtVAR_039892C183FSHH_HUMANDisease (HPE3)  ---A/BC183F
33UniProtVAR_062611C183RSHH_HUMANDisease (HPE3)  ---A/BC183R
34UniProtVAR_062612C183YSHH_HUMANDisease (HPE3)  ---A/BC183Y
35UniProtVAR_062613S184LSHH_HUMANDisease (HPE3)  ---A/BS184L
36UniProtVAR_009166E188QSHH_HUMANDisease (HPE3)587778799A/BE188Q

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (36, 36)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_062593P26LSHH_HUMANDisease (HPE3)  ---AP26L
02UniProtVAR_039888G27ASHH_HUMANDisease (HPE3)  ---AG27A
03UniProtVAR_003619G31RSHH_HUMANDisease (HPE3)28936675AG31R
04UniProtVAR_062594L39PSHH_HUMANDisease (HPE3)  ---AL39P
05UniProtVAR_062595E53KSHH_HUMANDisease (HPE3)  ---AE53K
06UniProtVAR_062596D83VSHH_HUMANDisease (HPE3)  ---AD83V
07UniProtVAR_062597I84FSHH_HUMANDisease (HPE3)  ---AI84F
08UniProtVAR_009163D88VSHH_HUMANDisease (HPE3)104894050AD88V
09UniProtVAR_009164Q100HSHH_HUMANDisease (HPE3)587778792AQ100H
10UniProtVAR_062598C102RSHH_HUMANDisease (HPE3)  ---AC102R
11UniProtVAR_062599C102YSHH_HUMANDisease (HPE3)  ---AC102Y
12UniProtVAR_062600L109FSHH_HUMANDisease (HPE3)  ---AL109F
13UniProtVAR_023806A110DSHH_HUMANDisease (HPE3)  ---AA110D
14UniProtVAR_062601A110TSHH_HUMANDisease (HPE3)  ---AA110T
15UniProtVAR_017883I111FSHH_HUMANDisease (SMMCI)104894049AI111F
16UniProtVAR_039889I111NSHH_HUMANDisease (HPE3)  ---AI111N
17UniProtVAR_009165N115KSHH_HUMANDisease (HPE3)267607047AN115K
18UniProtVAR_003620W117GSHH_HUMANDisease (HPE3)104894040AW117G
19UniProtVAR_003621W117RSHH_HUMANDisease (HPE3)104894040AW117R
20UniProtVAR_062602V124MSHH_HUMANDisease (HPE3)  ---AV124M
21UniProtVAR_062603E136KSHH_HUMANDisease (HPE3)  ---AE136K
22UniProtVAR_039890H140PSHH_HUMANDisease (HPE3)  ---AH140P
23UniProtVAR_039891H140QSHH_HUMANDisease (HPE3)  ---AH140Q
24UniProtVAR_062604G143DSHH_HUMANDisease (HPE3)  ---AG143D
25UniProtVAR_062605R144PSHH_HUMANDisease (HPE3)  ---AR144P
26UniProtVAR_062606D147NSHH_HUMANDisease (HPE3)  ---AD147N
27UniProtVAR_062607T150KSHH_HUMANDisease (HPE3)  ---AT150K
28UniProtVAR_023807T150RSHH_HUMANDisease (HPE3)  ---AT150R
29UniProtVAR_062608S156RSHH_HUMANDisease (HPE3)  ---AS156R
30UniProtVAR_062609F170CSHH_HUMANDisease (HPE3)  ---AF170C
31UniProtVAR_062610D171HSHH_HUMANDisease (HPE3)  ---AD171H
32UniProtVAR_039892C183FSHH_HUMANDisease (HPE3)  ---AC183F
33UniProtVAR_062611C183RSHH_HUMANDisease (HPE3)  ---AC183R
34UniProtVAR_062612C183YSHH_HUMANDisease (HPE3)  ---AC183Y
35UniProtVAR_062613S184LSHH_HUMANDisease (HPE3)  ---AS184L
36UniProtVAR_009166E188QSHH_HUMANDisease (HPE3)587778799AE188Q

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (36, 36)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_062593P26LSHH_HUMANDisease (HPE3)  ---BP26L
02UniProtVAR_039888G27ASHH_HUMANDisease (HPE3)  ---BG27A
03UniProtVAR_003619G31RSHH_HUMANDisease (HPE3)28936675BG31R
04UniProtVAR_062594L39PSHH_HUMANDisease (HPE3)  ---BL39P
05UniProtVAR_062595E53KSHH_HUMANDisease (HPE3)  ---BE53K
06UniProtVAR_062596D83VSHH_HUMANDisease (HPE3)  ---BD83V
07UniProtVAR_062597I84FSHH_HUMANDisease (HPE3)  ---BI84F
08UniProtVAR_009163D88VSHH_HUMANDisease (HPE3)104894050BD88V
09UniProtVAR_009164Q100HSHH_HUMANDisease (HPE3)587778792BQ100H
10UniProtVAR_062598C102RSHH_HUMANDisease (HPE3)  ---BC102R
11UniProtVAR_062599C102YSHH_HUMANDisease (HPE3)  ---BC102Y
12UniProtVAR_062600L109FSHH_HUMANDisease (HPE3)  ---BL109F
13UniProtVAR_023806A110DSHH_HUMANDisease (HPE3)  ---BA110D
14UniProtVAR_062601A110TSHH_HUMANDisease (HPE3)  ---BA110T
15UniProtVAR_017883I111FSHH_HUMANDisease (SMMCI)104894049BI111F
16UniProtVAR_039889I111NSHH_HUMANDisease (HPE3)  ---BI111N
17UniProtVAR_009165N115KSHH_HUMANDisease (HPE3)267607047BN115K
18UniProtVAR_003620W117GSHH_HUMANDisease (HPE3)104894040BW117G
19UniProtVAR_003621W117RSHH_HUMANDisease (HPE3)104894040BW117R
20UniProtVAR_062602V124MSHH_HUMANDisease (HPE3)  ---BV124M
21UniProtVAR_062603E136KSHH_HUMANDisease (HPE3)  ---BE136K
22UniProtVAR_039890H140PSHH_HUMANDisease (HPE3)  ---BH140P
23UniProtVAR_039891H140QSHH_HUMANDisease (HPE3)  ---BH140Q
24UniProtVAR_062604G143DSHH_HUMANDisease (HPE3)  ---BG143D
25UniProtVAR_062605R144PSHH_HUMANDisease (HPE3)  ---BR144P
26UniProtVAR_062606D147NSHH_HUMANDisease (HPE3)  ---BD147N
27UniProtVAR_062607T150KSHH_HUMANDisease (HPE3)  ---BT150K
28UniProtVAR_023807T150RSHH_HUMANDisease (HPE3)  ---BT150R
29UniProtVAR_062608S156RSHH_HUMANDisease (HPE3)  ---BS156R
30UniProtVAR_062609F170CSHH_HUMANDisease (HPE3)  ---BF170C
31UniProtVAR_062610D171HSHH_HUMANDisease (HPE3)  ---BD171H
32UniProtVAR_039892C183FSHH_HUMANDisease (HPE3)  ---BC183F
33UniProtVAR_062611C183RSHH_HUMANDisease (HPE3)  ---BC183R
34UniProtVAR_062612C183YSHH_HUMANDisease (HPE3)  ---BC183Y
35UniProtVAR_062613S184LSHH_HUMANDisease (HPE3)  ---BS184L
36UniProtVAR_009166E188QSHH_HUMANDisease (HPE3)587778799BE188Q

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (0, 0)

(no "PROSITE Motif" information available for 3M1N)

(-) Exons   (0, 0)

(no "Exon" information available for 3M1N)

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:164
 aligned with SHH_HUMAN | Q15465 from UniProtKB/Swiss-Prot  Length:462

    Alignment length:164
                                    34        44        54        64        74        84        94       104       114       124       134       144       154       164       174       184    
            SHH_HUMAN    25 GPGRGFGKRRHPKKLTPLAYKQFIPNVAEKTLGASGRYEGKISRNSERFKELTPNYNPDIIFKDEENTGADRLMTQRCKDKLNALAISVMNQWPGVKLRVTEGWDEDGHHSEESLHYEGRAVDITTSDRDRSKYGMLARLAVEAGFDWVYYESKAHIHCSVKAE 188
               SCOP domains d3m1na_ A: automated matches                                                                                                                                         SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ......................ee.......................hhhhhee.....eee......hhh.eehhhhhhhhhhhhhhhhhhh....eeeee...........hhhhhh.eeeeee...hhhhhhhhhhhhhhh...eeeeee..eeeee.... Sec.struct. author
             SAPs(SNPs) (1) -LA---R-------P-------------K-----------------------------VF---V-----------H-R------FDF---K-G------M-----------K---P--DP--N--K-----R-------------CH-----------FL---Q SAPs(SNPs) (1)
             SAPs(SNPs) (2) -----------------------------------------------------------------------------Y-------TN-----R----------------------Q---------R--------------------------------R----- SAPs(SNPs) (2)
             SAPs(SNPs) (3) --------------------------------------------------------------------------------------------------------------------------------------------------------------Y----- SAPs(SNPs) (3)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript -------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 3m1n A  25 GPGRGFGKRRHPKKLTPLAYKQFIPNVAEKTLGASGRYEGKISRNSERFKELTPNYNPDIIFKDEENTGADRLMTQRCKDKLNALAISVMNQWPGVKLRVTEGWDEDGHHSEESLHYEGRAVDITTSDRDRSKYGMLARLAVEAGFDWVYYESKAHIHCSVKAE 188
                                    34        44        54        64        74        84        94       104       114       124       134       144       154       164       174       184    

Chain B from PDB  Type:PROTEIN  Length:168
 aligned with SHH_HUMAN | Q15465 from UniProtKB/Swiss-Prot  Length:462

    Alignment length:168
                                    32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182        
            SHH_HUMAN    23 ACGPGRGFGKRRHPKKLTPLAYKQFIPNVAEKTLGASGRYEGKISRNSERFKELTPNYNPDIIFKDEENTGADRLMTQRCKDKLNALAISVMNQWPGVKLRVTEGWDEDGHHSEESLHYEGRAVDITTSDRDRSKYGMLARLAVEAGFDWVYYESKAHIHCSVKAENS 190
               SCOP domains d3m1nb_ B: automated matches                                                                                                                                             SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
           Pfam domains (1) --HH_signal-3m1nB02 B:25-184                                                                                                                                      --Hint Pfam domains (1)
           Pfam domains (2) --HH_signal-3m1nB03 B:25-184                                                                                                                                      ------ Pfam domains (2)
         Sec.struct. author ........................ee.....................hhhhhhhee.....eee......hhh.eehhhhhhhhhhhhhhhhhhh....eeeee...........hhhhhh.eeeeee...hhhhhhhhhhhhhhh...eeeeee..eeeee...... Sec.struct. author
             SAPs(SNPs) (1) ---LA---R-------P-------------K-----------------------------VF---V-----------H-R------FDF---K-G------M-----------K---P--DP--N--K-----R-------------CH-----------FL---Q-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -------------------------------------------------------------------------------Y-------TN-----R----------------------Q---------R--------------------------------R------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ----------------------------------------------------------------------------------------------------------------------------------------------------------------Y------- SAPs(SNPs) (3)
                    PROSITE ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ PROSITE
                 Transcript ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Transcript
                 3m1n B  23 IIGPGRGFGKRRHPKKLTPLAYKQFIPNVAEKTLGASGRYEGKISRNSERFKELTPNYNPDIIFKDEENTGADRLMTQRCKDKLNALAISVMNQWPGVKLRVTEGWDEDGHHSEESLHYEGRAVDITTSDRDRSKYGMLARLAVEAGFDWVYYESKAHIHCSVKAENS 190
                                    32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182        

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 2)

Asymmetric Unit

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 3M1N)

(-) Pfam Domains  (2, 3)

Asymmetric Unit
(-)
Clan: H-int (15)

(-) Gene Ontology  (199, 199)

Asymmetric Unit(hide GO term definitions)
Chain A,B   (SHH_HUMAN | Q15465)
molecular function
    GO:0005509    calcium ion binding    Interacting selectively and non-covalently with calcium ions (Ca2+).
    GO:0005539    glycosaminoglycan binding    Interacting selectively and non-covalently with any glycan (polysaccharide) containing a substantial proportion of aminomonosaccharide residues.
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0043237    laminin-1 binding    Interacting selectively and non-covalently with laminin-1, a glycoprotein trimer with the subunit composition alpha1, beta1, gamma1.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0016015    morphogen activity    Acts as a trigger for a pattern specification process when present at a specific concentration within a gradient.
    GO:0005113    patched binding    Interacting selectively and non-covalently with the patched (ptc) protein, a receptor for hedgehog proteins.
    GO:0008233    peptidase activity    Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0008270    zinc ion binding    Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
    GO:0060020    Bergmann glial cell differentiation    The process in which neuroepithelial cells of the neural tube give rise to Brgmann glial cells, specialized bipotential progenitors cells of the cerebellum. Differentiation includes the processes involved in commitment of a cell to a specific fate.
    GO:0043369    CD4-positive or CD8-positive, alpha-beta T cell lineage commitment    The process in which an immature T cell commits to CD4-positive T cell lineage or the CD8-positive lineage of alpha-beta T cells.
    GO:0033077    T cell differentiation in thymus    The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus.
    GO:0048856    anatomical structure development    The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
    GO:0048646    anatomical structure formation involved in morphogenesis    The developmental process pertaining to the initial formation of an anatomical structure from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
    GO:0008209    androgen metabolic process    The chemical reactions and pathways involving androgens, C19 steroid hormones that can stimulate the development of male sexual characteristics.
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0048645    animal organ formation    The process pertaining to the initial formation of an animal organ from unspecified parts. The process begins with the specific processes that contribute to the appearance of the discrete structure, such as inductive events, and ends when the structural rudiment of the organ is recognizable, such as a condensation of mesenchymal cells into the organ rudiment. Organs are a natural part or structure in an animal or a plant, capable of performing some special action (termed its function), which is essential to the life or well-being of the whole. The heart and lungs are organs of animals, and the petal and leaf are organs of plants. In animals the organs are generally made up of several tissues, one of which usually predominates, and determines the principal function of the organ.
    GO:0009952    anterior/posterior pattern specification    The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
    GO:0097190    apoptotic signaling pathway    A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
    GO:0060840    artery development    The progression of the artery over time, from its initial formation to the mature structure. An artery is a blood vessel that carries blood away from the heart to a capillary bed.
    GO:0007411    axon guidance    The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
    GO:0007596    blood coagulation    The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
    GO:0001569    branching involved in blood vessel morphogenesis    The process of coordinated growth and sprouting of blood vessels giving rise to the organized vascular system.
    GO:0060442    branching involved in prostate gland morphogenesis    The process in which the branching structure of the prostate gland is generated and organized. A branch is a division or offshoot from a main stem.
    GO:0060445    branching involved in salivary gland morphogenesis    The process in which the branching structure of the salivary gland is generated and organized.
    GO:0001658    branching involved in ureteric bud morphogenesis    The process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
    GO:0048754    branching morphogenesis of an epithelial tube    The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
    GO:0060447    bud outgrowth involved in lung branching    The process in which a region of the lung epithelium initiates an outgrowth.
    GO:0043010    camera-type eye development    The process whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
    GO:0060070    canonical Wnt signaling pathway    The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
    GO:0048468    cell development    The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
    GO:0045165    cell fate commitment    The commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
    GO:0001708    cell fate specification    The process involved in the specification of cell identity. Once specification has taken place, a cell will be committed to differentiate down a specific pathway if left in its normal environment.
    GO:0008283    cell proliferation    The multiplication or reproduction of cells, resulting in the expansion of a cell population.
    GO:0007267    cell-cell signaling    Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
    GO:0071285    cellular response to lithium ion    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus.
    GO:0007417    central nervous system development    The process whose specific outcome is the progression of the central nervous system over time, from its formation to the mature structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain and spinal cord. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord.
    GO:0021930    cerebellar granule cell precursor proliferation    The multiplication or reproduction of neuroblasts that will give rise to granule cells. A granule cell is a glutamatergic interneuron found in the cerebellar cortex.
    GO:0003140    determination of left/right asymmetry in lateral mesoderm    The establishment of the lateral mesoderm with respect to the left and right halves.
    GO:0007368    determination of left/right symmetry    The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
    GO:0048589    developmental growth    The increase in size or mass of an entire organism, a part of an organism or a cell, where the increase in size or mass has the specific outcome of the progression of the organism over time from one condition to another.
    GO:0048546    digestive tract morphogenesis    The process in which the anatomical structures of the digestive tract are generated and organized. The digestive tract is the anatomical structure through which food passes and is processed.
    GO:0071542    dopaminergic neuron differentiation    The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
    GO:0021904    dorsal/ventral neural tube patterning    The process in which the neural tube is regionalized in the dorsoventral axis.
    GO:0009953    dorsal/ventral pattern formation    The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
    GO:0007398    ectoderm development    The process whose specific outcome is the progression of the ectoderm over time, from its formation to the mature structure. In animal embryos, the ectoderm is the outer germ layer of the embryo, formed during gastrulation.
    GO:0009790    embryo development    The process whose specific outcome is the progression of an embryo from its formation until the end of its embryonic life stage. The end of the embryonic stage is organism-specific. For example, for mammals, the process would begin with zygote formation and end with birth. For insects, the process would begin at zygote formation and end with larval hatching. For plant zygotic embryos, this would be from zygote formation to the end of seed dormancy. For plant vegetative embryos, this would be from the initial determination of the cell or group of cells to form an embryo until the point when the embryo becomes independent of the parent plant.
    GO:0048557    embryonic digestive tract morphogenesis    The process in which the anatomical structures of the digestive tract are generated and organized during embryonic development. The digestive tract is the anatomical structure through which food passes and is processed.
    GO:0042733    embryonic digit morphogenesis    The process, occurring in the embryo, by which the anatomical structures of the digit are generated and organized. A digit is one of the terminal divisions of an appendage, such as a finger or toe.
    GO:0048617    embryonic foregut morphogenesis    The process in which the anatomical structures of the foregut are generated and organized, during the embryonic phase.
    GO:0035115    embryonic forelimb morphogenesis    The process, occurring in the embryo, by which the anatomical structures of the forelimb are generated and organized. The forelimbs are the front limbs of an animal, e.g. the arms of a human.
    GO:0035116    embryonic hindlimb morphogenesis    The process, occurring in the embryo, by which the anatomical structures of the hindlimbs are generated and organized. The hindlimbs are the posterior limbs of an animal.
    GO:0030326    embryonic limb morphogenesis    The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
    GO:0048598    embryonic morphogenesis    The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants.
    GO:0048568    embryonic organ development    Development, taking place during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
    GO:0009880    embryonic pattern specification    The process that results in the patterns of cell differentiation that will arise in an embryo.
    GO:0048706    embryonic skeletal system development    The process, occurring during the embryonic phase, whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure.
    GO:0006897    endocytosis    A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.
    GO:0060664    epithelial cell proliferation involved in salivary gland morphogenesis    The multiplication or reproduction of epithelial cells of the submandibular salivary gland, resulting in the expansion of a cell population and the shaping of the gland.
    GO:0060441    epithelial tube branching involved in lung morphogenesis    The process in which a highly ordered sequence of patterning events generates the branched epithelial tubes of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.
    GO:0060684    epithelial-mesenchymal cell signaling    Any process that results in the transfer of information from an epithelial cell to a mesenchymal cell where it is interpreted.
    GO:0060738    epithelial-mesenchymal signaling involved in prostate gland development    Any process that results in the transfer of information from an epithelial cell to a mesenchymal cell where it is interpreted and contributes to the progression of the prostate gland over time.
    GO:0030010    establishment of cell polarity    The specification and formation of anisotropic intracellular organization or cell growth patterns.
    GO:0030900    forebrain development    The process whose specific outcome is the progression of the forebrain over time, from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).
    GO:0048859    formation of anatomical boundary    The process in which the limits of an anatomical structure are generated. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
    GO:0001942    hair follicle development    The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
    GO:0031069    hair follicle morphogenesis    The process in which the anatomical structures of the hair follicle are generated and organized.
    GO:0007507    heart development    The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
    GO:0001947    heart looping    The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
    GO:0030902    hindbrain development    The process whose specific outcome is the progression of the hindbrain over time, from its formation to the mature structure. The hindbrain is the posterior of the three primary divisions of the developing chordate brain, or the corresponding part of the adult brain (in vertebrates, includes the cerebellum, pons, and medulla oblongata and controls the autonomic functions and equilibrium).
    GO:0007442    hindgut morphogenesis    The process in which the anatomical structures of the hindgut are generated and organized.
    GO:0048839    inner ear development    The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
    GO:0016539    intein-mediated protein splicing    The removal of an internal amino acid sequence (an intein) from a protein during protein maturation; the excision of inteins is precise and the N- and C-terminal exteins are joined by a normal peptide bond. Protein splicing involves 4 nucleophilic displacements by the 3 conserved splice junction residues.
    GO:0045109    intermediate filament organization    Control of the spatial distribution of intermediate filaments; includes organizing filaments into meshworks, bundles, or other structures, as by cross-linking.
    GO:0001822    kidney development    The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
    GO:0060459    left lung development    The biological process whose specific outcome is the progression of a left lung from an initial condition to its mature state. This process begins with the formation of the left lung and ends with the mature structure. The left lung is the lung which is on the left side of the anterior posterior axis looking from a dorsal to ventral aspect.
    GO:0060174    limb bud formation    The process pertaining to the initial formation of a limb bud from unspecified parts. This process begins with the formation of a local condensation of mesenchyme cells within the prospective limb field, and ends when a limb bud is recognizable.
    GO:0060173    limb development    The process whose specific outcome is the progression of a limb over time, from its formation to the mature structure. A limb is an appendage of an animal used for locomotion or grasping. Examples include legs, arms or some types of fin.
    GO:0030324    lung development    The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
    GO:0060428    lung epithelium development    The biological process whose specific outcome is the progression of the lung epithelium from an initial condition to its mature state. This process begins with the formation of lung epithelium and ends with the mature structure. The lung epithelium is the specialized epithelium that lines the inside of the lung.
    GO:0060463    lung lobe morphogenesis    The process in which the anatomical structures of a lung lobe are generated and organized. A lung lobe is a projection that extends from the lung.
    GO:0060425    lung morphogenesis    The process in which the anatomical structures of the lung are generated and organized.
    GO:0060484    lung-associated mesenchyme development    The biological process whose specific outcome is the progression of a lung-associated mesenchyme from an initial condition to its mature state. This process begins with the formation of lung-associated mesenchyme and ends with the mature structure. Lung-associated mesenchyme is the tissue made up of loosely connected mesenchymal cells in the lung.
    GO:0002320    lymphoid progenitor cell differentiation    The process in which a precursor cell type acquires the specialized features of a lymphoid progenitor cell. Lymphoid progenitor cells include progenitor cells for any of the lymphoid lineages.
    GO:0030539    male genitalia development    The process whose specific outcome is the progression of the male genitalia over time, from its formation to the mature structure.
    GO:0010463    mesenchymal cell proliferation    The multiplication or reproduction of cells, resulting in the expansion of a mesenchymal cell population. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.
    GO:0060916    mesenchymal cell proliferation involved in lung development    The multiplication or reproduction of cells, resulting in the expansion of a mesenchymal cell population that contributes to the progression of the lung over time. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.
    GO:0060783    mesenchymal smoothened signaling pathway involved in prostate gland development    The series of molecular signals generated as a consequence of activation of the transmembrane Smoothened-type protein in the mesenchymal cells of the prostate that contribute to the progression of the prostate over time. This process contributes to lung development.
    GO:0072136    metanephric mesenchymal cell proliferation involved in metanephros development    The multiplication or reproduction of cells, resulting in the expansion of a metanephric mesenchymal cell population.
    GO:0001656    metanephros development    The process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. In mammals, the metanephros is the excretory organ of the fetus, which develops into the mature kidney and is formed from the rear portion of the nephrogenic cord. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine.
    GO:0030901    midbrain development    The process whose specific outcome is the progression of the midbrain over time, from its formation to the mature structure. The midbrain is the middle division of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes a ventral part containing the cerebral peduncles and a dorsal tectum containing the corpora quadrigemina and that surrounds the aqueduct of Sylvius connecting the third and fourth ventricles).
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0045445    myoblast differentiation    The process in which a relatively unspecialized cell acquires specialized features of a myoblast. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into striated muscle fibers.
    GO:0014902    myotube differentiation    The process in which a relatively unspecialized cell acquires specialized features of a myotube cell. Myotube differentiation starts with myoblast fusion and the appearance of specific cell markers (this is the cell development step). Then individual myotubes can fuse to form bigger myotubes and start to contract. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
    GO:0042130    negative regulation of T cell proliferation    Any process that stops, prevents or reduces the rate or extent of T cell proliferation.
    GO:0030178    negative regulation of Wnt signaling pathway    Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway.
    GO:0046639    negative regulation of alpha-beta T cell differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of alpha-beta T cell differentiation.
    GO:0043066    negative regulation of apoptotic process    Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
    GO:0090090    negative regulation of canonical Wnt signaling pathway    Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
    GO:0045596    negative regulation of cell differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of cell differentiation.
    GO:0030336    negative regulation of cell migration    Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.
    GO:0090370    negative regulation of cholesterol efflux    Any process that decreases the frequency, rate or extent of cholesterol efflux. Cholesterol efflux is the directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.
    GO:1904339    negative regulation of dopaminergic neuron differentiation    Any process that stops, prevents or reduces the frequency, rate or extent of dopaminergic neuron differentiation.
    GO:0010629    negative regulation of gene expression    Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:2000357    negative regulation of kidney smooth muscle cell differentiation    Any process that stops, prevents or reduces the frequency, rate or extent of kidney smooth muscle cell differentiation.
    GO:2001054    negative regulation of mesenchymal cell apoptotic process    Any process that stops, prevents or reduces the frequency, rate or extent of mesenchymal cell apoptotic process.
    GO:0032435    negative regulation of proteasomal ubiquitin-dependent protein catabolic process    Any process that stops, prevents, or reduces the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
    GO:0042177    negative regulation of protein catabolic process    Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
    GO:0034244    negative regulation of transcription elongation from RNA polymerase II promoter    Any process that stops, prevents, or reduces the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.
    GO:0000122    negative regulation of transcription from RNA polymerase II promoter    Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:2000062    negative regulation of ureter smooth muscle cell differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of ureter smooth muscle cell differentiation.
    GO:0045060    negative thymic T cell selection    The process of elimination of immature T cells in the thymus which react strongly with self-antigens.
    GO:0001755    neural crest cell migration    The characteristic movement of cells from the dorsal ridge of the neural tube to a variety of locations in a vertebrate embryo.
    GO:0007405    neuroblast proliferation    The expansion of a neuroblast population by cell division. A neuroblast is any cell that will divide and give rise to a neuron.
    GO:0048663    neuron fate commitment    The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron.
    GO:0080125    obsolete multicellular structure septum development    OBSOLETE. The process whose specific outcome is the progression of the multicellular structure septum over time, from its formation to the mature structure. The multicellular structure septum is the thin partition or membrane that divides a cavity or a mass of tissue.
    GO:0042476    odontogenesis    The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
    GO:0042475    odontogenesis of dentin-containing tooth    The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
    GO:0014003    oligodendrocyte development    The process aimed at the progression of an oligodendrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An oligodendrocyte is a type of glial cell involved in myelinating the axons in the central nervous system.
    GO:0048709    oligodendrocyte differentiation    The process in which a relatively unspecialized cell acquires the specialized features of an oligodendrocyte. An oligodendrocyte is a type of glial cell involved in myelinating the axons of neurons in the central nervous system.
    GO:0002076    osteoblast development    The process whose specific outcome is the progression of an osteoblast over time, from its formation to the mature structure. Osteoblast development does not include the steps involved in committing a cranial neural crest cell or an osteoprogenitor cell to an osteoblast fate. An osteoblast is a cell that gives rise to bone.
    GO:0060021    palate development    The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities.
    GO:0031016    pancreas development    The process whose specific outcome is the progression of the pancreas over time, from its formation to the mature structure. The pancreas is an endoderm derived structure that produces precursors of digestive enzymes and blood glucose regulating enzymes.
    GO:0007389    pattern specification process    Any developmental process that results in the creation of defined areas or spaces within an organism to which cells respond and eventually are instructed to differentiate.
    GO:0009949    polarity specification of anterior/posterior axis    Any process resulting in the establishment of polarity along the anterior/posterior axis.
    GO:0033089    positive regulation of T cell differentiation in thymus    Any process that activates or increases the frequency, rate or extent of T cell differentiation in the thymus.
    GO:0030177    positive regulation of Wnt signaling pathway    Any process that activates or increases the frequency, rate or extent of Wnt signal transduction.
    GO:0046638    positive regulation of alpha-beta T cell differentiation    Any process that activates or increases the frequency, rate or extent of alpha-beta T cell differentiation.
    GO:0045597    positive regulation of cell differentiation    Any process that activates or increases the frequency, rate or extent of cell differentiation.
    GO:0051781    positive regulation of cell division    Any process that activates or increases the frequency, rate or extent of cell division.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0021940    positive regulation of cerebellar granule cell precursor proliferation    The process that activates or increases the rate or extent of granule cell precursor proliferation.
    GO:0060769    positive regulation of epithelial cell proliferation involved in prostate gland development    Any process that increases the rate, frequency or extent of epithelial cell proliferation that contributes to the progression of the prostate gland over time.
    GO:0010628    positive regulation of gene expression    Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0007228    positive regulation of hh target transcription factor activity    Any process that increases the activity of a transcription factor that activates transcription of Hedgehog-target genes in response to Smoothened signaling. In Drosophila, Cubitus interruptus (Ci) is the only identified transcription factor so far in the Hedgehog signaling pathway. In vertebrates, members of the Gli protein family are activated in this way. Activation of the Gli/Ci transcription factor is distinct from its stabilization, when proteolytic cleavage is inhibited.
    GO:0033092    positive regulation of immature T cell proliferation in thymus    Any process that activates or increases the frequency, rate or extent of immature T cell proliferation in the thymus.
    GO:2000358    positive regulation of kidney smooth muscle cell differentiation    Any process that activates or increases the frequency, rate or extent of kidney smooth muscle cell differentiation.
    GO:0002053    positive regulation of mesenchymal cell proliferation    The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
    GO:2000729    positive regulation of mesenchymal cell proliferation involved in ureter development    Any process that activates or increases the frequency, rate or extent of mesenchymal cell proliferation involved in ureter development.
    GO:0002052    positive regulation of neuroblast proliferation    Any process that activates or increases the rate of neuroblast proliferation.
    GO:0048714    positive regulation of oligodendrocyte differentiation    Any process that activates or increases the frequency, rate or extent of oligodendrocyte differentiation.
    GO:0042307    positive regulation of protein import into nucleus    Any process that activates or increases the frequency, rate or extent of movement of proteins from the cytoplasm into the nucleus.
    GO:0061189    positive regulation of sclerotome development    Any process that increases the rate, frequency, or extent of the progression of the sclerotome over time, from its initial formation to the mature structure. The sclerotome is the portion of the somite that will give rise to a vertebra.
    GO:0014858    positive regulation of skeletal muscle cell proliferation    Any process that activates or increases the frequency, rate or extent of skeletal muscle cell proliferation.
    GO:0048643    positive regulation of skeletal muscle tissue development    Any process that activates, maintains or increases the rate of skeletal muscle tissue development.
    GO:0045880    positive regulation of smoothened signaling pathway    Any process that activates or increases the frequency, rate or extent of smoothened signaling.
    GO:0051155    positive regulation of striated muscle cell differentiation    Any process that activates or increases the frequency, rate or extent of striated muscle cell differentiation.
    GO:0045944    positive regulation of transcription from RNA polymerase II promoter    Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0045893    positive regulation of transcription, DNA-templated    Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
    GO:2000063    positive regulation of ureter smooth muscle cell differentiation    Any process that activates or increases the frequency, rate or extent of ureter smooth muscle cell differentiation.
    GO:0045059    positive thymic T cell selection    The process of sparing immature T cells in the thymus which react with self-MHC protein complexes with low affinity levels from apoptotic death.
    GO:0060516    primary prostatic bud elongation    The increase in size of the prostatic bud as it forms.
    GO:0060523    prostate epithelial cord elongation    The developmental growth process in which solid chords of prostate epithelium increase in length.
    GO:0030850    prostate gland development    The process whose specific outcome is the progression of the prostate gland over time, from its formation to the mature structure. The prostate gland is a partly muscular, partly glandular body that is situated near the base of the mammalian male urethra and secretes an alkaline viscid fluid which is a major constituent of the ejaculatory fluid.
    GO:0034504    protein localization to nucleus    A process in which a protein transports or maintains the localization of another protein to the nucleus.
    GO:0006508    proteolysis    The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
    GO:0042127    regulation of cell proliferation    Any process that modulates the frequency, rate or extent of cell proliferation.
    GO:0060768    regulation of epithelial cell proliferation involved in prostate gland development    Any process that modulates the rate, frequency or extent of epithelial cell proliferation that contributes to the progression of the prostate gland over time.
    GO:0010468    regulation of gene expression    Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0060782    regulation of mesenchymal cell proliferation involved in prostate gland development    Any process that modulates the frequency, rate or extent of mesenchymal cell proliferation that contributes to the progression of the prostate gland over time. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.
    GO:1900175    regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry    Any process that modulates the frequency, rate or extent of a nodal signaling pathway, where the nodal signaling pathway is involved in determination of left/right asymmetry in the lateral mesoderm.
    GO:0042481    regulation of odontogenesis    Any process that modulates the frequency, rate or extent of the formation and development of a tooth or teeth.
    GO:0060685    regulation of prostatic bud formation    Any process that modulates the rate, frequency, or extent of prostatic bud formation, the morphogenetic process in which a region of the fetal urogenital sinus epithelium is specified to become the prostate, resulting in prostate bud outgrowth.
    GO:1900180    regulation of protein localization to nucleus    Any process that modulates the frequency, rate or extent of protein localization to nucleus.
    GO:0030162    regulation of proteolysis    Any process that modulates the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein.
    GO:0006355    regulation of transcription, DNA-templated    Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0072001    renal system development    The process whose specific outcome is the progression of the renal system over time, from its formation to the mature structure. The renal system maintains fluid balance and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels.
    GO:0030323    respiratory tube development    The process whose specific outcome is the progression of the respiratory tube over time, from its formation to the mature structure. The respiratory tube is assumed to mean any tube in the respiratory tract.
    GO:0060458    right lung development    The biological process whose specific outcome is the progression of a right lung from an initial condition to its mature state. This process begins with the formation of the right lung and ends with the mature structure. The right lung is the lung which is on the right side of the anterior posterior axis looking from a dorsal to ventral aspect.
    GO:0060662    salivary gland cavitation    The process in which the solid core of salivary epithelium gives rise to the hollow tube of the gland.
    GO:0043588    skin development    The process whose specific outcome is the progression of the skin over time, from its formation to the mature structure. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner vascular dermis (cutis, corium or true skin) composed mostly of connective tissue.
    GO:0007224    smoothened signaling pathway    A series of molecular signals generated as a consequence of activation of the transmembrane protein Smoothened.
    GO:0021938    smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation    The series of molecular signals generated as a consequence of activation of the transmembrane protein Smoothened in cerebellar granule cells that contributes to the regulation of proliferation of the cells.
    GO:0061053    somite development    The progression of a somite from its initial formation to the mature structure. Somites are mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
    GO:0021513    spinal cord dorsal/ventral patterning    The process that regulates the coordinated growth and differentiation that establishes the non-random dorsal-ventral spatial arrangement of the spinal cord.
    GO:0021522    spinal cord motor neuron differentiation    The process in which neuroepithelial cells in the ventral neural tube acquire specialized structural and/or functional features of motor neurons. Motor neurons innervate an effector (muscle or glandular) tissue and are responsible for transmission of motor impulses from the brain to the periphery. Differentiation includes the processes involved in commitment of a cell to a specific fate.
    GO:0048864    stem cell development    The process whose specific outcome is the progression of the stem cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to its specific fate.
    GO:0051146    striated muscle cell differentiation    The process in which a relatively unspecialized cell acquires specialized features of a striated muscle cell; striated muscle fibers are divided by transverse bands into striations, and cardiac and voluntary muscle are types of striated muscle.
    GO:0014706    striated muscle tissue development    The process whose specific outcome is the progression of a striated muscle over time, from its formation to the mature structure. Striated muscle contain fibers that are divided by transverse bands into striations, and cardiac and skeletal muscle are types of striated muscle. Skeletal muscle myoblasts fuse to form myotubes and eventually multinucleated muscle fibers. The fusion of cardiac cells is very rare and can only form binucleate cells.
    GO:0021978    telencephalon regionalization    The regionalization process that creates areas within the forebrain that will direct the behavior of cell migration in differentiation as the telencephalon develops.
    GO:0021794    thalamus development    The process in which the thalamus changes over time, from its initial formation to its mature state.
    GO:0048538    thymus development    The process whose specific outcome is the progression of the thymus over time, from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells, with unique vascular, nervous, epithelial, and lymphoid cell components.
    GO:0030878    thyroid gland development    The process whose specific outcome is the progression of the thyroid gland over time, from its formation to the mature structure. The thyroid gland is an endoderm-derived gland that produces thyroid hormone.
    GO:0060438    trachea development    The process whose specific outcome is the progression of a trachea over time, from its formation to the mature structure. The trachea is the portion of the airway that attaches to the bronchi as it branches.
    GO:0060439    trachea morphogenesis    The process in which a trachea is generated and organized. The trachea is the portion of the airway that attaches to the bronchi as it branches.
    GO:0001944    vasculature development    The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
    GO:0001570    vasculogenesis    The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
    GO:0007418    ventral midline development    The process whose specific outcome is the progression of the ventral midline over time, from its formation to the mature structure. In protostomes (such as insects, snails and worms) as well as deuterostomes (vertebrates), the midline is an embryonic region that functions in patterning of the adjacent nervous tissue. The ventral midline in insects is a cell population extending along the ventral surface of the embryo and is the region from which cells detach to form the ventrally located nerve cords. In vertebrates, the midline is originally located dorsally. During development, it folds inwards and becomes the ventral part of the dorsally located neural tube and is then called the ventral midline, or floor plate.
cellular component
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005829    cytosol    The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
    GO:0005788    endoplasmic reticulum lumen    The volume enclosed by the membranes of the endoplasmic reticulum.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0005622    intracellular    The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0045121    membrane raft    Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0005578    proteinaceous extracellular matrix    A layer consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that forms a sheet underlying or overlying cells such as endothelial and epithelial cells. The proteins are secreted by cells in the vicinity. An example of this component is found in Mus musculus.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    SO4  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    ZN  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
    BC1  [ RasMol ]  +environment [ RasMol ]
    BC2  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Gly B:25 - Pro B:26   [ RasMol ]  
    Ile A:48 - Pro A:49   [ RasMol ]  
    Ile B:48 - Pro B:49   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  3m1n
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  SHH_HUMAN | Q15465
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  142945
    Disease InformationOMIM
  147250
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  SHH_HUMAN | Q15465
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        SHH_HUMAN | Q154653ho5 3mxw

(-) Related Entries Specified in the PDB File

(no "Related Entries Specified in the PDB File" available for 3M1N)